|
Volumn 7, Issue 6, 2013, Pages 561-565
|
An international atherosclerosis society position paper: Global recommendations for the management of dyslipidemia
|
Author keywords
Atherosclerosis; Cardiovascular risk; Cholesterol; Lifestyle therapies; Lipoproteins; Statins
|
Indexed keywords
BILE ACID RESIN;
EZETIMIBE;
FIBRIC ACID DERIVATIVE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
NICOTINIC ACID;
OMEGA 3 FATTY ACID;
RESIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
VERY LOW DENSITY LIPOPROTEIN;
ARTICLE;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CALORIC INTAKE;
CALORIE;
CHOLESTEROL BLOOD LEVEL;
CHOLESTEROL INTAKE;
CHRONIC KIDNEY DISEASE;
DIABETES MELLITUS;
DYSLIPIDEMIA;
FAMILIAL HYPERCHOLESTEROLEMIA;
FAMILY HISTORY;
FRAMINGHAM RISK SCORE;
GENETIC EPIDEMIOLOGY;
HIGH RISK POPULATION;
HUMAN;
HYPERTENSION;
HYPERTRIGLYCERIDEMIA;
LIFESTYLE MODIFICATION;
LOW RISK POPULATION;
MEDICAL SOCIETY;
METABOLIC SYNDROME X;
PHYSICAL ACTIVITY;
PHYSICAL INACTIVITY;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
QRISK SCORE;
RISK ASSESSMENT;
RISK REDUCTION;
SECONDARY PREVENTION;
SMOKING;
SODIUM INTAKE;
TRIACYLGLYCEROL BLOOD LEVEL;
ATHEROSCLEROSIS;
CARDIOVASCULAR RISK;
CHOLESTEROL;
LIFESTYLE THERAPIES;
LIPOPROTEINS;
STATINS;
ANTICHOLESTEREMIC AGENTS;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
DIET;
DYSLIPIDEMIAS;
HUMANS;
METABOLIC SYNDROME X;
RISK FACTORS;
SOCIETIES, MEDICAL;
|
EID: 84889657257
PISSN: 19332874
EISSN: 18764789
Source Type: Journal
DOI: 10.1016/j.jacl.2013.10.001 Document Type: Review |
Times cited : (131)
|
References (0)
|